Myanmar court adjourns verdict in 2nd case against Suu KyiTomateros extends lead over Navojoa in postseasonÓmicron disrupts trips but not seasonal purchases in the USAP Sports News Headlines 6:17 am GMTNuggets beat Clippers with JokicPrescott and Cowboys crush Washington 56-14Why Boosters Provide Drastic Protection Against Sudden Coronavirus Spikes In CaliforniaNew South Wales Reports 6,324 New COVID CasesCaetano Veloso tests positive for covid-19Bulls beat Pacers 113-105, string together three winsA very low-cost antidepressant reduced the need for hospitalization among adults with COVID-19 with other health problems, part of a study on existing drugs that could be used against the coronavirus.Researchers tested the pill used to treat depression and obsessive-compulsive disorder because it is known to reduce inflammation, and it showed promising results in small-scale studies.The researchers shared the results with the US National Institutes of Health, which publishes the treatment guidelines, and they hope the World Health Organization will recommend them."If the WHO recommends this, they will see that it will be widely adopted," said study co-author Dr. Edward Mills of McMaster University in Hamilton, Ontario, noting that many poor nations already have wide availability of this drug."Hopefully this leads to many lives being saved."The full COVID-19 treatment of the pill, called fluvoxamine, would cost about $ 4.By comparison, intravenous antibody treatments cost about $ 2,000, and Merck's experimental antiviral drug for COVID-19 is worth about $ 700 for the entire treatment.Some experts predict that a combination of several treatments will eventually be used to fight the coronavirus.The researchers tested the antidepressant on nearly 1,500 Brazilians who were recently infected with coronavirus and who were at risk of severe illness due to other health problems, such as diabetes.About half of them took the antidepressant at home for 10 days, while the rest received placebos.They were followed for four weeks to see who went to the hospital or spent additional time in emergency rooms when hospitals were full.In the group that took the pill, 11% required hospitalization or extended emergency room care, compared with 16% of the group that received placebos.The results, published Wednesday in the Lancet Global Health journal, were so robust that independent experts monitoring the study recommended that it be stopped earlier than expected due to the forcefulness of the results.There are still questions about what is the best dose, if lower-risk patients would also benefit, and if the pill should be combined with other treatments.The large-scale project tested eight existing drugs to see if they could be used against the coronavirus.The project is still testing one drug for hepatitis, but the rest - including metformin, hydroxychloroquine and ivermectin - have not been successful.The low-priced generic and Merck's COVID-19 drug work differently and "could be complementary," said Dr. Paul Sax of Brigham and Women's Hospital and Harvard Medical School, who was not involved in the discussion. study.This month, Merck asked regulators in the United States and Europe to authorize its antiviral pill.More science and technologyThe new pills against COVID-19Digital nomads: living traveling is now a realityNew COVID-19 drugs may have limited impact on the fight against omicron this winterOmicron, how it works and what remains to be learnedModerna says its reinforcement is effective against omicronUCSD fears a massive wave of COVID will hit San Diego around the New Year.Here is the reasonLatino Life at The San Diego Union-TribuneCalifornia's racial inequality: What can state do with $ 31 billion?Border wait times swell as staffing shortages plague inspections boothsYMCA: Border View reopening in early 2022 with a new model for equityReceive the latest news in Spanish Monday, Wednesday and Friday.Subscribe to our newsletterYou may occasionally receive promotional content from the San Diego Union-Tribune en Español.To ensure that the San Diego Union-Tribune en Español continues to be healthy and strong, your donation, in any measure, is now more important than ever.Help us continue to inform the community.To donate click on the logo.Missouri: Woman kills boyfriend with sword on Christmas EveChivas signs the winger Roberto Alvarado heading to the ClausuraSpurs set season mark in 144-109 winThunder halts Pelicans' four-game win streakA lawyer who defended the case Roe v.WadeYMCA: Border View reopens in early 2022 with a new equity modelCavaliers pass over depleted Raptors 144-99Fires ravage Argentine Patagonia and southern ChileGrizzlies overwhelm Kings for second time in 10 daysEmbiid shines as 76ers overtake WizardsOld Pennsylvania Church Announces Final ClosureBears beat Seahawks in dramatic finalePrivacy Policy Privacy Policy Terms of Service Sign Up For Our Newsletters